Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Trial of Kamlanoflast In Patients With Amyotrophic Lateral Sclerosis

NCT07396818 is registered in ClinicalTrials.gov with Inflammasome Therapeutics as lead sponsor.

NCT NCT07396818
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07396818 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Trial of Kamlanoflast In Patients With Amyotrophic Lateral Sclerosis
Lead sponsor
Inflammasome Therapeutics
Phase
Phase 1/2
Overall status
Not yet recruiting
Start date
February 28, 2026
Completion date
January 31, 2027
Enrollment
40 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

als, als (amyotrophic lateral sclerosis), motor neuron disease (mnd), neuro-degenerative disease, neuro-degenerative diseases